NICE nod for GSK’s ‘bubble baby syndrome’ gene therapy
admin 23rd October 2017 Uncategorised 0The National Institute for Health and Care Excellence has published draft guidance recommending GlaxoSmithKline’s gene therapy Strimvelis as an option for treating an ultra-rare immune deficiency condition commonly referred to as bubble baby syndrome.
More: NICE nod for GSK’s ‘bubble baby syndrome’ gene therapy
Source: News